Nurse's Death Linked to Weight-Loss Drug

This is a UK news story, published by BBC, that relates primarily to Susan McGowan news.

UK news

For more UK news, you can click here:

more UK news

Susan McGowan news

For more Susan McGowan news, you can click here:

more Susan McGowan news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

BBC news

For more news from BBC, you can click here:

more news from BBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

prescribed tirzepatide

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest loss drugs news, prescription news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

loss drug

BBC

•

Nurse's death linked to weight-loss drug Mounjaro approved on NHS

Summary

Nutrition label

76% Informative

Susan McGowan , 58 , took two low-dose injections of tirzepatide, known under the brand name Mounjaro , over the course of about two weeks before her death on 4 September .

Her death certificate lists multiple organ failure, septic shock and pancreatitis as the immediate cause of death.

It is thought to be the first death officially linked to the drug in the UK .

Tirzepatide became the subject of national debate recently when the UK government announced plans to roll it out to unemployed people to help them back into work.

The government is partnering with the Mounjaro manufacturer to run a five-year trial in Greater Manchester .

Nearly 250,000 people are expected to receive the jab over the next three years as part of the trial.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive